Search - tctmd.com

Displaying 101 - 120 of 177

Sort: Relevancy | Date

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

First-in-Human Study of a Novel Transradial Device for Intra-aortic Embolic Deflection During TAVR Implantation

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Darren Mylotte

October 30, 2017

Presentation TCT 2017

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

October 29, 2017

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

Presentation TCT 2016

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Axel Linke

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Isnt Enough Transcervical Access With Flow Reversal Is the Ideal Strategy for CAS

Presenter: Sriram S. Iyer, John R. Laird Jr., Brian G. DeRubertis

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek

November 01, 2016

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Editorial Perspective: Embolic Protection in TAVR Intervention

Presenter: Josep Rodés-Cabau

October 31, 2016

Advertisement

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

First-in-Human Study of a Novel Transradial Device for Intra-aortic Embolic Deflection During TAVR Implantation

Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Isnt Enough Transcervical Access With Flow Reversal Is the Ideal Strategy for CAS

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Editorial Perspective: Embolic Protection in TAVR Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content